{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

Patient 1

HOPE
Holistic opinion on pancreatic exocrine insufficiency (Prevalence, diagnosis & management)
  1. How many patients of chronic pancreatitis do you see in a month? *

  2. The major causes of chronic pancreatitis according to you are? *

    3. Rate on a scale of (1- Most common, 2 – Less common, 3 – Least common, 4 Not seen)

    Rating
    Hypertriglyceridemia
    High Alcohol Consumption
    Gallstones
    Hereditary
    Cystic Fibrosis
  3. The most common symptoms in patients with chronic pancreatitis are? *

    4. Rate on scale of (1- Most common, 2 – Less common, 3 – Least common, 4 Not seen)

    Rating
    Abdominal Pain
    Fatty bulky stools
    Weight Loss
    Loss of Appetite
    Nausea and Vomiting
  4. How many patients in your practice present with pancreatic exocrine insufficiency (PEI) due to chronic pancreatitis in a month? *

  5. How many patients of diabetes mellitus present with pancreatic exocrine insufficiency in a month? *

  6. How many patients of pancreatic cancer present with pancreatic exocrine insufficiency in a month? *

  7. How many patients of cystic fibrosis present with pancreatic exocrine insufficiency in a month? *

  8. How many patients of pancreaticoduodenectomy present with pancreatic exocrine insufficiency in a month? *

  9. Which are the methods you consider to diagnose chronic pancreatitis? *

  10. What is/are the preferred test(s) to diagnose pancreatic exocrine insufficiency? *

  11. What are the parameters to assess the improvement in PEI? (Select all that apply) *

  12. Which are the preferred medications for the management of pancreatic exocrine insufficiency? *
    13. Kindly tick on preferable option
    Pancreatic enzyme replacement therapy (PERT)

    Vitamins

    Antioxidants

    NSAIDs

    Steroids

  13. In your practice, which parameters do you consider to start and decide the dose of PERT? *

  14. As per your practice, according to following strengths what is your preference based on severity and patient weight? (Kindly tick on preferable option) *

    15. <50 kg
    Lipase Units
    10000 25000 40000
    Mild

    Moderate

    Severe

    50-80 kg
    Lipase Units
    10000 25000 40000
    Mild

    Moderate

    Severe

    >80 kg
    Lipase Units
    10000 25000 40000
    Mild

    Moderate

    Severe

  15. What is the adherence rate of PERT in your patients? *

  16. Would you consider prescribing uncoated pancreatic enzymes for management of pain in chronic pancreatitis and later on stay with PERT (Coated Pancreatic Enzymes)? *

  17. If yes, what is the duration of uncoated enzyme therapy for pain management in chronic pancreatitis?

  18. Do you co-prescribe PPI along with uncoated enzymes in management of pain in chronic pancreatitis? *

  19. How long does it take to get symptomatic improvement with PERT in PEI patients? *

  20. PERT gives significant symptomatic improvement in PEI in diabetic patients. *

  21. PERT gives significant symptomatic improvement in PEI in patients with pancreatic cancer *

  22. PERT gives significant symptomatic improvement in PEI after pancreaticoduodenectomy *

  23. PERT gives significant symptomatic improvement in PEI in cystic fibrosis *

  24. How frequently do you do follow up of pancreatic exocrine insufficiency patient? *

  25. Do you consider co-prescribing antioxidant along with PERT therapy *

  26. Are pancreatic enzyme supplements well tolerated by your patients? *

  27. What are the factors which commonly lead to non-compliance to PERT? (Select all that apply) *

  28. Do you refer PEI patients to dieticians for dietary advice? *

  29. What dietary modification is recommended for adults with pancreatic insufficiency? (Select all that apply) *

  30. What are the lifestyle modifications commonly suggested to patients *